Lyras publishes 2024 financial report in line with strategic expectations
The 2024 results are in accordance with expectations and reflect the strategic realignment carried out in the second half of the year. The positive commercial development Lyras is experiencing in 2025 confirms that the company’s foundation is solidly established. Both organizationally and financially, Lyras is now strongly positioned to continue its journey of growth and take the next step in its development.
Following a half-year marked by commercial breakthroughs and strategic milestones, Lyras is entering a new phase. The Danish company, which developed the light-based liquid treatment technology, raslysation, has now completed its technology development phase and operates today as an operations-focused growth company with recurring sales, a healthy capital structure, and a clear expansion strategy, including entry into the pharmaceutical market.
“We have laid the foundation. The technology is in place, the business is growing, and we have recurring customers. Now it is about execution and scaling.” Says founder Rasmus Mortensen.
The first half of 2025 has been defined by the transition from a focus on technological maturity to operational scaling. Lyras has succeeded in establishing a business with recurring customers and deliveries across multiple markets. At the same time, the owners have provided the company with the freedom to execute its strategy without the need for new external capital.
After successful commercialization in the food and process industries, Lyras is now ready to expand its technology into the pharmaceutical industry. The next step is to adapt and document the technology to meet the high standards of the pharma sector, where contamination control and energy savings are critical parameters.
The strategic transformation from a technology company to an operations- and growth-focused business is also reflected in Lyras’ financial results. The outcome is as expected and underscores that Lyras is steering its own course, both commercially and financially. In the second half of 2024, the company implemented an organizational transformation to ensure the right setup to support commercial operations. These changes have been proven timely in light of the positive commercial development Lyras is experiencing in 2025. Organizationally and financially, Lyras is positioned to continue growing.
During the period, Lyras also entered partnerships with leading players in the global food technology industry. These collaborations aim to accelerate the adoption of raslysation across markets and production lines. The partnerships further validate both the technology and the company’s ability to deploy it on a scale.
Facts About Lyras and Raslysation
Lyras has developed the groundbreaking raslysation technology, which inactivates microorganisms in beverages and other opaque liquids using UV light. With raslysation, between 60–90% energy and 60–80% water can be saved compared to traditional pasteurization.
If a dairy processing 40 tons of whey per hour switches to raslysation instead of traditional pasteurization, it will emit approximately 850 fewer tons of CO₂ annually (based on EU averages). This is equivalent to the energy used to drive around the world 164 times in a typical gasoline-powered car.
Raslysation uses a UV light source equipped with a light filter that concentrates on a specific type of light. The liquid flows past the light in a controlled motion to ensure complete exposure. This effectively inactivates all unwanted microorganisms while preserving more of the original flavor, vitamins, and proteins.
